Osteoporosis disease management for fragility fracture patients: new understandings based on three years' experience with an osteoporosis care service

Arthritis Rheum. 2007 Dec 15;57(8):1502-6. doi: 10.1002/art.23093.

Abstract

Objective: To review the 3-year performance of an established osteoporosis care service and consider further improvements in an effort to reduce fragility fractures.

Methods: Osteoporosis care has been coordinated for all willing and able patients with orthopedic fragility fractures in our health system by a nurse and medical director since 2003, using a guideline-based care algorithm and task management software. Patients were followed by telephone for 2 years to monitor their status and optimize adherence to treatment. Demographics, management recommendations, clinical data, and adherence to treatment were reviewed for the 2003-2005 patient population.

Results: Of 1,019 patients with fragility fractures, 61% underwent osteoporosis evaluation and treatment. The remainder included 15% who refused to participate and 24% who were unable to participate for various logistical and health reasons. More patients age >80 years were unwilling or unable to participate. Bone densities (dual x-ray absorptiometry [DXA]) were normal, low, or osteoporotic in 24%, 55%, and 21% of patients, respectively, and 60% of the osteoporotic group had > or = 1 abnormal metabolic bone laboratory result. Only 17% of the total reported a previous fracture, and 47% had ever undergone DXA. Few experienced bone loss, a new fracture, or bisphosphonate intolerance during treatment.

Conclusion: An osteoporosis care service has coordinated care for every willing and able fragility fracture patient with positive outcomes. In addition, the results suggest a high priority for earlier proactive diagnosis and intervention of the at-risk population if fractures are to be reduced.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorptiometry, Photon
  • Aged
  • Aged, 80 and over
  • Algorithms
  • Bone Density / drug effects
  • Bone Density / physiology
  • Bone Density Conservation Agents / therapeutic use
  • Diphosphonates / therapeutic use
  • Fractures, Spontaneous / etiology*
  • Fractures, Spontaneous / prevention & control*
  • Humans
  • Interviews as Topic
  • Longitudinal Studies
  • Middle Aged
  • Osteoporosis / complications*
  • Osteoporosis / physiopathology
  • Osteoporosis / therapy*
  • Risk Factors
  • Treatment Outcome

Substances

  • Bone Density Conservation Agents
  • Diphosphonates